Near Remote Method to Guide Performance of Regional Anesthesia
Launched by DR. GLENIO MIZUBUTI (MD, MSC) · Jul 21, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help doctors learn how to perform a type of pain relief called regional anesthesia, which can be done with the help of ultrasound technology. This technique is important because it can reduce the need for strong pain medications, making it safer for patients and improving their overall experience in the hospital. The trial will use a method called "near remote" guidance, where experienced doctors (mentors) will help train less experienced doctors (trainees) through live video on their devices while they perform the procedure.
To participate in this trial, mentors must be expert anesthesiologists, and trainees should be senior residents or emergency medicine physicians who are already familiar with regional blocks. Patients who are at least 18 years old and are having surgery or have injuries that can be treated with regional blocks may also be eligible. Throughout the trial, participants will share their thoughts on this new teaching method, helping to improve the training process for future doctors. If you or someone you know fits this description, this trial may provide a valuable opportunity to contribute to advances in medical education and patient care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Mentors: Staff anesthesiologists who are experts in regional blocks.
- • Trainees: Senior (PGY3-5) residents (anesthesiology and emergency medicine), and staff (emergency medicine) physicians who have already performed and are comfortable with being supervised near remotely for the regional block at hand.
- • Patients: Greater or equal to 18 years of age presenting for surgery or with traumatic injuries amenable to regional blocks.
- • All of the above: Able to read and understand English, and competent to provide written informed consent.
- Exclusion Criteria:
- • Mentors: Staff anesthesiologists who are not experts in the performance/teaching of regional blocks.
- • Trainees: Junior (PGY1-2) residents (for any/all types of regional blocks), and senior (PGY3-5) residents and staff physicians who are not comfortable with being supervised near remotely for the regional block at hand.
- • Patients: Less than 18 years of age.
- • All of the above: Unable to read and understand English, and not competent to provide written informed consent.
About Dr. Glenio Mizubuti (Md, Msc)
Dr. Glenio Mizubuti, MD, MSc, is a distinguished clinical trial sponsor with extensive expertise in clinical research and patient care. With a robust medical background and a master's degree in clinical sciences, Dr. Mizubuti is dedicated to advancing medical knowledge through rigorous and ethically conducted clinical trials. His commitment to innovation and excellence in patient outcomes drives his leadership in the development of new therapies and treatments, ensuring that each study adheres to the highest standards of scientific integrity and regulatory compliance. Dr. Mizubuti’s collaborative approach fosters strong partnerships with research institutions and healthcare professionals, ultimately aiming to translate research findings into meaningful clinical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kingston, Ontario, Canada
Patients applied
Trial Officials
Glenio B. Mizubuti, MD, MSc, FRCPC
Principal Investigator
Queen's University. Department of Anesthesiology and Perioperative Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported